Senior Director, Pharmacological Sciences and Screening Technologies at Bristol-Myers Squibb

Winter Garden, Florida, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Ph.D. in Pharmacology, Cell Biology, Biochemistry, or a related scientific discipline
Extensive industry experience (10+ years) in drug discovery
Proven track record of successfully advancing programs from target concept to preclinical candidate selection
Deep expertise in diverse in vitro assay technologies, including cell-based and biochemical assays, high-throughput screening (HTS)
Passionate and innovative scientist
Proven portfolio leader, collaborator, and innovator

Responsibilities

Act as a subject matter expert, setting the strategic vision for the in vitro pharmacology team and ensuring the adoption of cutting-edge technologies and approaches, including staying current on the latest advancements in screening methodologies
Oversee and guide the design, optimization, and validation of cellular, biochemical, and biophysical assays to support target identification, high-throughput screening (HTS), and lead optimization
Lead and manage hit generation, screening, and molecular profiling activities for multiple drug discovery programs across different therapeutic areas
Work extensively in a matrix environment, collaborating with various departments such as medicinal chemistry, biology, computational sciences, and toxicology to advance drug discovery pipelines
Ensure the generation of high-quality data and use advanced software for data analysis, archiving, and interpretation to guide program decisions
Manage and lead a multi-disciplinary team of scientists across biochemistry and cellular pharmacology groups to impact and progress an exciting and innovative portfolio of novel therapeutics
Supervise multiple PhD and advanced leaders and scientists within their teams
Manage technology infrastructure, future innovation, and strategy
Foster a culture of transparency, innovation, career development, and collaboration
Accountable for oncology small molecule portfolio oversight, strategic vision setting, and cross-geography (Cambridge, MA and Lawrenceville, NJ) collaborations

Skills

Oncology

Small Molecule

Drug Discovery

Pharmacological Sciences

Screening Technologies

Biophysics

Structural Biology

Chemical Biology

Translational Biology

Synthetic Chemistry

Computational Chemistry

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free